In vivo dual targeting of the oncogenic Ether-à-go-go-1 potassium channel by calcitriol and astemizole results in enhanced antineoplastic effects in breast tumors. (Q34325900)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | In vivo dual targeting of the oncogenic Ether-à-go-go-1 potassium channel by calcitriol and astemizole results in enhanced antineoplastic effects in breast tumors. |
scientific article |
Statements
In vivo dual targeting of the oncogenic Ether-à-go-go-1 potassium channel by calcitriol and astemizole results in enhanced antineoplastic effects in breast tumors (English)
Janice García-Quiroz
Nancy Santos-Martínez
David Barrera
David Ordaz-Rosado
Euclides Avila
Ali Halhali
Octavio Villanueva
Maŕa J Ibarra-Sánchez
José Esparza-López
Armando Gamboa-Domínguez
Javier Camacho
Fernando Larrea
3 October 2014
1 reference
1 reference
1 reference